Charles Schumacher

Biopharmaceutical Research Co. is a specialty pharmaceutical company that focuses on providing safe and effective options for treating patients with innovative cannabinoid therapeutics. The company is based in Castroville, CA. The company holds several DEA registrations across the entire value chain of cannabis and is pioneering the federally legal cannabis space in the USA. BRC has full DEA compliance for botanically derived cannabinoids and has developed proprietary poly-cannabinoids in titratable dosages that are soon to enter the clinic. The company was founded in 2017 by George Bennett Hodgin, who has been the CEO since 2017.

Biopharmaceutical Research Co. is a specialty pharmaceutical company that focuses on providing safe and effective options for treating patients with innovative cannabinoid therapeutics. The company is based in Castroville, CA. The company holds several DEA registrations across the entire value chain of cannabis and is pioneering the federally legal cannabis space in the USA. BRC has full DEA compliance for botanically derived cannabinoids and has developed proprietary poly-cannabinoids in titratable dosages that are soon to enter the clinic. The company was founded in 2017 by George Bennett Hodgin, who has been the CEO since 2017.